|
|
News Breaks
|
November 13, 2009
|
| 06:45 EDT |  | WCRX |
| theflyonthewall.com: | Warner Chilcott files to sell 20M shares of common stock | | Goldman Sachs, Morgan Stanley, Credit Suisse and J.P. Morgan are joint book-runners for the offering. :theflyonthewall.com |
|
|
News For WCRX From The Last 14 Days Check below for free stories on WCRX the last two weeks.
There are 3 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 9, 2012
|
| 07:38 EDT |  | WCRX |
| theflyonthewall.com: | Mylan announces final FDA approval of generic Doryx | | Mylan (MYL) announced that it received final approval from the FDA for its Abbreviated New Drug Application for Doxycycline Hyclate Delayed-release Tablets USP, 150 mg. This product is the generic version of Mayne Pharma's Doryx, which is marketed by Warner Chilcott (WCRX). The company said the FDA denied Warner Chilcott's Citizen Petition. Mylan agreed that it will not launch its generic Doryx product until after a decision is issued in Warner Chilcott's patent infringement lawsuit against Mylan. This trial is underway in the U.S. District Court for the District of New Jersey and a decision is currently expected in March. :theflyonthewall.com |
|
|
January 30, 2012
|
| 11:07 EDT | | WCRX |
| | 08:41 EDT |  | WCRX |
| theflyonthewall.com: | Warner Chilcott price target lowered to $23 from $24 at Susquehanna | | Susquehanna lowered its price target on Warner Chilcott following the company's lowered guidance. The firm maintains its Positive rating citing valuation, the belief there is an increased urgency on business development, and continued growth in its core business. :theflyonthewall.com |
|
|
|
|
|
Subscribe for More Information